Posted in | News | Nanomedicine

Researcher Works on Delivering Chemotherapeutics Using Nano-Vehicles for Cancer Treatment

Jeremy L. Steinbacher, PhD, is among a new generation of scientists trying to improve their aim and approach to killing cancer cells. The Canisius College professor of chemistry/biochemistry is working to develop biomedical agents that more accurately target and attack tumors.

“When cancer is treated with traditional chemotherapy the drug goes everywhere in the body with the hope that it reaches enough malignant cells to kill them,” explains Steinbacher. It’s a proven cancer treatment but chemotherapy also damages healthy cells and triggers debilitating side effects. Steinbacher’s research involves new, safer ways to deliver this life-saving therapy. “The idea is to package up chemotherapeutics inside microscopic nano-vehicles, which then go straight to the source of the diseased tissue,” says Steinbacher. “If we can do that, we can then deliver higher doses of the drug to just the tumor, and patients won’t suffer side effects or damage to healthy tissue.”

For more information about Stenbacher’s research, contact Eileen Herbert in the Canisius College Office of Public Relations at 716-888-2791 or at [email protected].

Source: http://www.canisius.edu

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.